French govt endorses Alzheimer Europe call

16 July 2006

France's Minister for Social Welfare, the Elderly, the Disabled and the Family, Philippe Bas, has expressed "the full support of the French government to the outlined priorities" of the 16th Alzheimer Europe Conference, held in Paris, France, under the auspices of President Jacques Chirac, according to a statement released by the association.

Mr Bas also thanked Alzheimer groups from across Europe for their "important contribution to the ongoing discussions in France and throughout Europe."

Maurice O'Connell, chairperson of Alzheimer's Europe responded, saying: "my organization is delighted by this clear support of the French government to the political priorities outlined by us." He added: "with the numbers of people with dementia predicted to double or treble by 2050, the time for action is now."

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >

Today's issue

Company Spotlight

Ironwood is a US-based biotech advancing a pipeline of medicines in multiple areas of significant unmet need, including irritable bowel syndrome with constipation ((IBS-C)/chronic idiopathic constipation (CIC), vascular and fibrotic diseases, and refractory gastroesophageal reflux disease, among others.